BIOMAT Database Logo BIOMAT Database Logo

FK 506 affects platelet aggregation in vitro. 1994

J Malyszko, and Y Takada, and T Urano, and A Takada
Department of Physiology, Hamamatsu University School of Medicine, Shizuoka, Japan.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

J Malyszko, and Y Takada, and T Urano, and A Takada
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
December 1991, Transplantation proceedings,
J Malyszko, and Y Takada, and T Urano, and A Takada
Influence of mycophenolic acid and FK-506 on human platelet activation in vitro.
January 2000, Kidney & blood pressure research,
J Malyszko, and Y Takada, and T Urano, and A Takada
FK 506/fluconazole interaction enhances FK 506 nephrotoxicity.
January 1994, Diabete & metabolisme,
J Malyszko, and Y Takada, and T Urano, and A Takada
FK 506.
February 1991, Lancet (London, England),
J Malyszko, and Y Takada, and T Urano, and A Takada
Mechanisms by which FK 506 affects exocrine pancreas in rats.
December 1991, Transplantation proceedings,
J Malyszko, and Y Takada, and T Urano, and A Takada
In vitro FK 506 kidney tubular cell toxicity.
December 1991, Transplantation proceedings,
J Malyszko, and Y Takada, and T Urano, and A Takada
Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate.
June 1998, Transplantation proceedings,
J Malyszko, and Y Takada, and T Urano, and A Takada
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
September 1987, The Journal of antibiotics,
J Malyszko, and Y Takada, and T Urano, and A Takada
Tacrolimus (FK 506).
September 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
J Malyszko, and Y Takada, and T Urano, and A Takada
FK 506 in transplantation.
August 1993, Transplantation proceedings,
Copied contents to your clipboard!